Acknowledgements
F.P. is listed as inventor of the US patent n. 9 669 109 ‘A modified
human U1snRNA molecule, a gene encoding for the modified human U1snRNA
molecule, an expression vector including the gene, and the use thereof
in gene therapy of familial dysautonomia and spinal muscular atrophy’.
As such the inventors could potentially benefit from any future
commercial exploitation of patent rights, including the use of ExspeU1s
in CF.